Documented Failures of Animal Testing – When Lives Were Lost or Harmed

Thalidomide (pregnancy anti-nausea drug)

    • Harm: Up to 30,000 infants born with severe malformations.

    • Animal Tests: “Safe” in 10+ species (rats, rabbits, dogs, primates, cats, pigs, etc.)

    • Reality: Animal models failed to predict human teratogenicity.

Vioxx (arthritis drug)

    • Harm: 320,000 heart attacks, strokes, and cardiac events; estimated 140,000 deaths.

    • Animal Tests: Showed protective cardiac effects in multiple species.

    • Reality: Caused cardiovascular toxicity in humans, leading to withdrawal in 2004.

Isuprel (asthma medication)

    • Harm: 3,500 deaths in the UK alone due to cardiac complications.

    • Animal Tests: Used on rats, guinea pigs, dogs, and monkeys.

    • Reality: Doses safe in animals led to human deaths.

TGN1412 (autoimmune therapy)

    • Harm: 6 healthy human volunteers experienced cytokine storm and organ failure at 1/500th of the dose tested in animals.

    • Animal Tests: Safe in monkeys.

    • Reality: Left volunteers with lifelong damage; one nearly died within hours.

BIA-102474-101 (neurological drug)

    • Harm: Brain hemorrhage and death in clinical trial; 5 others critically harmed.

    • Animal Tests: Safe in dogs at doses 500x higher.

    • Reality: One man died; study halted.

Fialuridine (hepatitis B treatment)

    • Harm: 5 human deaths; 2 others suffered organ failure.

    • Animal Tests: No liver toxicity in mice, rats, dogs, monkeys, or woodchucks.

    • Reality: Human-specific mitochondrial toxicity.

Fasiglifam (type 2 diabetes drug)

    • Harm: Human clinical trials showed liver toxicity, halted development.

    • Animal Tests: No toxicity observed.

    • Reality: Human transcriptomic screening showed mitochondrial dysfunction missed by animals.

Troglitazone (type 2 diabetes drug)

    • Harm: Withdrawn after causing fatal liver failure in humans.

    • Animal Tests: Approved based on safety in multiple species.

    • Reality: Liver-on-a-chip correctly predicted hepatotoxicity; animals did not.

Curcumin (CF drug candidate)

    • Harm: False hope and wasted research efforts.

    • Animal Tests: Seemed to improve CFTR function in mice.

    • Reality: Shown to be completely ineffective in human cells and organoids.

Oraflex (benoxaprofen)

    • Use: Anti-inflammatory drug (arthritis)

    • Animal Tests: Safe in rats, dogs, and monkeys

    • Harm: Withdrawn after causing fatal liver toxicity and skin reactions in humans

    • Reality: Caused 3,500+ adverse events and several deaths before being removed from the market in the UK and US (1982)

Phenacetin

    • Use: Painkiller (related to paracetamol)

    • Animal Tests: Safe in rats and other models

    • Harm: Linked to kidney cancer and renal failure in long-term human use

    • Reality: Withdrawn from many markets globally after epidemiological data confirmed the risks

Practolol (beta-blocker)

    • Use: Heart arrhythmia and hypertension

    • Animal Tests: Showed no toxicity

    • Harm: Caused vision loss, skin damage, and death in humans

    • Reality: Withdrawn after severe adverse effects were confirmed

Rezulin 

    • Use: Type 2 diabetes drug

    • Animal Tests: Cleared in preclinical testing

    • Harm: Caused hundreds of liver failure cases and deaths

    • Reality: Withdrawn from the US market in 2000 — preceded troglitazone

Eraldin (prenylamine)

  • Use: Angina treatment

  • Animal Tests: Passed standard preclinical testing

  • Harm: Caused eye damage and sudden death in patients

  • Reality: Withdrawn after nearly a decade on the market (1970s)

 

These aren’t isolated tragedies — they are the inevitable outcome of trusting a broken system. Animal testing doesn’t just fail science, It fails animals and humans. 

Humans have almost missed out on lifesaving treatments if we had relied on the results of animal testing…

When animal tests falsely identify a safe chemical as “toxic,” the almost certain outcome is the drug is abandoned. There is no doubt that potentially beneficial drugs have failed animal testing and been lost to patients, even though they would have been both safe and effective [1,2]. 

Due to the fact that a drug which shows toxicity in animals is unlikely to ever undergo human testing, the magnitude of this type of “error” is unknown.

It is important to note that many highly beneficial drugs would have never been brought to market if animal testing was required as they would certainly fail animal testing. 

Notable examples inlcude:

  • Penicillin (fatal to guinea pigs) [3]
  • Paracetamol (toxic in dogs and cats) [4]
  • Aspirin (embryo toxicity in rats and rhesus monkeys) [5]

The lack of animal tests has also caused detrimental delays in critical drug approvals:

Compassionate human use of ganciclovir demonstrated efficacy and safety in treating AIDS–related cytomegalovirus retinitis (a blinding eye infection) in more human patients than would generally be required for a phase I clinical trial, but the FDA refused to license it due to lack of animal studies.

Ganciclovir had also been used safely in over 300 patients under compassionate use to treat the blinding eye infection (more than would generally be required in a phase II clinical trial) however the FDA delayed clinical trials for more than a year due to lack of animal studies.

The drug was finally approved after a 4-year delay [6].

For further reading, the following review article published in 2019 clearly articulates the many issues with animal testing: 

Limitations of Animal Studies for Predicting Toxicity in Clinical Trials